Search Results - Denis Franchimont
- Showing 1 - 20 results of 45
- Go to Next Page
-
1
-
2
-
3
L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation by Gilles Fortin, Katerina Yurchenko, Catherine Collette, Manuel Rubio, A-C Villani, Alain Bitton, Marika Sarfati, Denis Franchimont
Published 2009Artigo -
4
-
5
-
6
Tumor Necrosis Factor α Decreases, and Interleukin-10 Increases, the Sensitivity of Human Monocytes to Dexamethasone: Potential Regulation of the Glucocorticoid Receptor by Denis Franchimont, Henri Martens, Marie-Thérèse Hagelstein, Édouard Louis, Walthère Dewé, George P. Chrousos, Jacques Bélaïche, Vincent Geenen
Published 1999Artigo -
7
-
8
<i>PNPLA3</i>(rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis by Eric Trépo, Erwan Guyot, Nathalie Ganne‐Carrié, Delphine Degré, Thierry Gustot, Denis Franchimont, Angéla Sutton, Pierre Nahon, Christophe Moreno
Published 2011Carta -
9
Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease by Édouard Louis, C. Ribbens, A Godon, Denis Franchimont, D De Groote, N Hardy, Jacques Boniver, Jacques Bélaïche, Michel Malaise
Published 2000Artigo -
10
Inhibition of Th1 Immune Response by Glucocorticoids: Dexamethasone Selectively Inhibits IL-12-Induced Stat4 Phosphorylation in T Lymphocytes by Denis Franchimont, Jérôme Galon, Massimo Gadina, Roberta Visconti, Yong Zhou, Martin Aringer, David M. Frucht, George P. Chrousos, John J. O’Shea
Published 2000Artigo -
11
Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans by Édouard Louis, Denis Franchimont, Anthony Piron, Y. Gevaert, Nicole Schaaf‐Lafontaine, S. Roland, P Mahieu, Michel Malaise, Donat De Groote, Renaud Louis, Jacques Bélaïche
Published 1998Artigo -
12
Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study by Séverine Vermeire, F D’Heygere, A. Nakad, Denis Franchimont, Fernand Fontaine, Édouard Louis, Philippe Van Hootegem, Olivier Dewit, Guy Lambrecht, Beatrijs Strubbe, Filip Baert
Published 2018Artigo -
13
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor α by Denis Franchimont, Jérôme Galon, Melanie S. Vacchio, Samuel Fan, Roberta Visconti, David M. Frucht, Vincent Geenen, George P. Chrousos, Jonathan D. Ashwell, John J. O’Shea
Published 2002Artigo -
14
Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis by Alexandra‐Chloé Villani, Mathieu Lemire, Marroon Thabane, Alexandre Bélisle, Geneviève Geneau, Amit X. Garg, William F. Clark, Paul Moayyedi, Stephen M. Collins, Denis Franchimont, John K. Marshall
Published 2010Artigo -
15
Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease by Nathalie Franchimont, V Putzeys, J. Collette, Séverine Vermeire, P. Rutgeerts, Martine De Vos, A. Van Gossum, Denis Franchimont, René Fiasse, Paul Pelckmans, Michel Malaise, Jacques Bélaïche, E Louis
Published 2004Artigo -
16
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis by Martine De Vos, Olivier Dewit, Geert D’Haens, Filip Baert, F Fontaine, Séverine Vermeire, Denis Franchimont, Tom G. Moreels, Dirk Staessen, L. Terriere, Bert Vander Cruyssen, E Louis
Published 2011Artigo -
17
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study by Raphaël Maréchal, Bertrand Vos, Marc Polus, Thierry Delaunoit, Marc Peeters, Pieter Demetter, Alain Hendlisz, Anne Demols, Denis Franchimont, Gontran Verset, P. Van Houtte, J. Van de Stadt, Jean‐Luc Van Laethem
Published 2011Artigo -
18
An insertion deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases by Vinciane Dideberg, Guðrún Kristjánsdóttir, Lili Milani, Cécile Libioulle, Snævar Sigurðsson, Édouard Louis, A.-C. Wiman, Séverine Vermeire, Paul Rutgeerts, Jacques Bélaïche, Denis Franchimont, A. Van Gossum, Vincent Bours, A-C Syvänen
Published 2007Artigo -
19
Development of the IBD Disk by Subrata Ghosh, Édouard Louis, Laurent Beaugerie, Peter Bossuyt, Guillaume Bouguen, Arnaud Bourreille, Marc Ferrante, Denis Franchimont, Karen Frost, Xavier Hébuterne, John K. Marshall, Ciara O’Shea, Greg Rosenfeld, Chadwick Williams, Laurent Peyrin‐Biroulet
Published 2017Artigo -
20
Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab by Annick Moens, Karen van Hoeve, Evelien Humblet, Jean‐François Rahier, Peter Bossuyt, Sophie Dewit, Denis Franchimont, Elisabeth Macken, Jochen Nijs, A Posen, Beatrijs Strubbe, Anneleen Van Hootegem, Wouter Van Moerkercke, Séverine Vermeire, Marc Ferrante
Published 2018Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Disease
Biology
Genetics
Gene
Inflammatory bowel disease
Crohn's disease
Gastroenterology
Immunology
Ulcerative colitis
Pathology
Genotype
Endocrinology
Immune system
Infliximab
Surgery
Tumor necrosis factor alpha
Cytokine
Single-nucleotide polymorphism
Allele
Computational biology
Genetic association
Genome-wide association study
Inflammation
Chemotherapy
Haplotype
Prospective cohort study
Randomized controlled trial
Receptor